OLINK HOLDING AB - ADR (OLK)
US6807101000 - ADR
Overall OLK gets a fundamental rating of 4 out of 10. We evaluated OLK against 59 industry peers in the Life Sciences Tools & Services industry. OLK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OLK is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year OLK has reported negative net income.
OLK had a negative operating cash flow in the past year.
In the past 5 years OLK always reported negative net income.
OLK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
OLK has a Return On Assets of -5.25%. This is comparable to the rest of the industry: OLK outperforms 52.54% of its industry peers.
Looking at the Return On Equity, with a value of -6.29%, OLK is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.25% | ||
| ROE | -6.29% | ||
| ROIC | N/A |
ROA(3y)-5.28%
ROA(5y)-5.94%
ROE(3y)-6.12%
ROE(5y)-8.05%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OLK has a better Gross Margin (67.48%) than 94.92% of its industry peers.
In the last couple of years the Gross Margin of OLK has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for OLK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5YN/A
2. Health
2.1 Basic Checks
OLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OLK has a worse debt/assets ratio than last year.
2.2 Solvency
OLK has an Altman-Z score of 17.36. This indicates that OLK is financially healthy and has little risk of bankruptcy at the moment.
OLK has a better Altman-Z score (17.36) than 98.31% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that OLK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.05, OLK is doing good in the industry, outperforming 62.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 17.36 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
OLK has a Current Ratio of 4.75. This indicates that OLK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.75, OLK is in the better half of the industry, outperforming 71.19% of the companies in the same industry.
OLK has a Quick Ratio of 3.55. This indicates that OLK is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.55, OLK is doing good in the industry, outperforming 64.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.75 | ||
| Quick Ratio | 3.55 |
3. Growth
3.1 Past
OLK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -150.00%.
The Revenue has grown by 21.28% in the past year. This is a very strong growth!
Measured over the past years, OLK shows a very strong growth in Revenue. The Revenue has been growing by 46.35% on average per year.
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-220%
Revenue 1Y (TTM)21.28%
Revenue growth 3Y46.35%
Revenue growth 5YN/A
Revenue growth Q2Q18.42%
3.2 Future
OLK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.42% yearly.
OLK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.16% yearly.
EPS Next Y21.22%
EPS Next 2Y31.55%
EPS Next 3Y34.71%
EPS Next 5Y44.42%
Revenue Next Year7.89%
Revenue Next 2Y14.78%
Revenue Next 3Y19%
Revenue Next 5Y24.16%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OLK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OLK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OLK's earnings are expected to grow with 34.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.55%
EPS Next 3Y34.71%
5. Dividend
5.1 Amount
No dividends for OLK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OLINK HOLDING AB - ADR
NASDAQ:OLK (4/25/2024, 7:09:14 PM)
After market: 23.07 0 (0%)23.07
+0.64 (+2.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.87B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.25% | ||
| ROE | -6.29% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.48% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.75 | ||
| Quick Ratio | 3.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.22%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.28%
Revenue growth 3Y46.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y